Shanghai Fosun Pharmaceutical (SHA:600196) subsidiary Fosun Industrial plans to sell its stake in a hospital and clinic operator for $124.1 million, according to a Wednesday filing with the Shanghai bourse.
Fosun Industrial will transfer 9.4 million ordinary shares of the target company to Calcite Gem.
The deal, approved on Thursday, marks the company's exit from the parent company of Chinese medical service group Harmony Family.
The sale will generate about 650 million yuan in post-tax gains.
Shares of the company rose 1% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.